Related Experiment Video
Updated: Jun 26, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Hospital performance and differences by kidney function in the use of recommended therapies after non-ST-elevation
Uptal D Patel1, Fang-Shu Ou, E Magnus Ohman
1Division of Nephrology, Duke University Medical Center, Durham, NC, USA. patel080@mc.duke.edu
Insights
Patients with chronic kidney disease (CKD) and acute coronary syndromes receive less evidence-based therapy. Treatment disparities for CKD patients are more apparent at high-performing hospitals.
Area of Science:
- Cardiology
- Nephrology
- Health Services Research
Background:
- Chronic kidney disease (CKD) increases cardiac event risk, yet guideline therapies are underused.
- The impact of hospital performance on CKD patient care for acute coronary syndromes is not well understood.
Purpose of the Study:
- To investigate the relationship between hospital performance and the use of guideline-recommended therapies in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACSs) and varying degrees of kidney function.
- To identify potential treatment disparities in NSTE ACS patients with CKD.
Main Methods:
- An observational cohort study of 81,374 patients with NSTE ACSs treated at 327 US hospitals.
- Hospital performance was assessed by adherence to American Heart Association guidelines for acute and discharge therapies.
- Therapy use was stratified by estimated glomerular filtration rate (eGFR) and adjusted for patient and hospital factors.
Main Results:
- Higher-performing hospitals showed lower therapy prescribing rates for patients with reduced kidney function (lower eGFR).
- Lower-performing hospitals exhibited prescribing patterns less sensitive to eGFR, maintaining similar rates across kidney function levels.
- This suggests treatment disparities for CKD patients are more pronounced at top-performing institutions.
Conclusions:
- Patients with CKD admitted for NSTE ACSs are less likely to receive guideline-recommended treatments.
- Treatment disparities linked to CKD are most evident in hospitals with higher performance metrics.
- Further research is needed to address these disparities and improve care for CKD patients with ACS.
Background:
Chronic kidney disease (CKD) is associated with an increased risk of cardiac events and death; however, underuse of guideline-recommended therapies is widespread. The extent to which hospital performance affects the care of patients with CKD and non-ST-segment elevation acute coronary syndromes (NSTE ACSs) is unknown.
Study Design:
Observational cohort.
Setting & Participants:
81,374 patients with NSTE ACSs treated at 327 US hospitals.
Predictor:
Hospital performance, measured by quartiles of composite adherence to American Heart Association class I guidelines for therapy acutely (aspirin, beta-blockers, clopidogrel, heparin, and glycoprotein IIb/IIIa inhibitors) and at discharge (aspirin, clopidogrel, angiotensin-converting enzyme inhibitors, and lipid-lowering agents) in eligible patients.
Outcomes & Measurements:
Use of each American Heart Association class I acute and discharge therapy stratified by continuous estimated glomerular filtration rate (eGFR). Multivariable models were adjusted for demographics, clinical factors, and hospital features.
Results:
Better-performing hospitals had lower prescribing rates for most therapies (5 of 9) with lower levels of kidney function, whereas lower-performing hospitals were more likely to have similar prescribing rates across the eGFR spectrum, suggesting that prescribing patterns at these hospitals were insensitive to differences in eGFR.
Limitations:
Observational design, selection bias of study cohort.
Conclusion:
Patients with lower levels of kidney function admitted with NSTE ACSs are less likely to receive evidence-based therapies. Treatment disparities related to CKD are most evident at top-performing hospitals.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Kidney Injury VI: Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview